¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Toxicity report series."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® toxicity ÇÑ±Û µ¶¼º
¼³¸í   
  »ýü¿¡ À־ٶ÷Á÷ÇÏÁö ¾ÊÀº ¾à¹° ÀÛ¿ëÀ» ¸»ÇÑ´Ù. ¾à¹°À» °ú·®À¸·Î »ç¿ëÇϸé Áßµ¶À» ÀÏÀ¸Å°¸ç, ½ÉÇÑ °æ¿ì¿¡´Â Á×À½¿¡ À̸£´Âµ¥ À̴ ¾à¹°ÀÇ ±Þ¼º µ¶¼ºÀÌ´Ù. ¸¸¼º µ¶¼ºÀº ¼Ò·®À» Àå±â°£ ¹Ýº¹ ¼·ÃëÇÏ¿´À» ¶§ÀÇ µ¶¼ºÀÌ´Ù. °£, ÄáÆÏ µî ¿©·¯ Àå±â¿Í Á¶Á÷¿¡ ´ëÇÑ µ¶¼º ¿Ü¿¡, ±âÇüÀ¯¹ß¼º, ¹ß¾Ï¼º µîµµ ¾à¹°µ¶¼ºÀÌ´Ù. ¾à¹°µ¶¼ºÀÇ °­¾àÀº ±Þ¼º µ¶¼º°Ë»ç(LD50), ¸¸¼º µ¶¼º°Ë»ç, ±âÇüÀ¯¹ß°Ë»ç, ¹ß¾Ï°Ë»ç, ¹ø½Ä°Ë»ç ±âŸ ¿©·¯ µ¿¹°°Ë»ç¿¡ ÀÇÇØ ÆÇÁ¤µÈ´Ù.
¿µ¹® upper GI series ÇÑ±Û »óºÎÀ§Àå°üÁ¶¿µ¼ú
¼³¸í   
  X-¼± »çÁø¿¡¼­ Àß ³ªÅ¸³ª´Â Á¶¿µÁ¦(¹æ»ç¼±ÃÔ¿µ»ó¿¡¼­ ÇϾé°Ô ³ªÅ¸³ª ÁÖÀ§Á¶Á÷°ú °¨º°ÀÌ ¿ëÀÌÇÏ´Ù)¸¦ ¼·ÃëÇÑ ÈÄ ½Äµµ, À§, »ùâÀÚ, ÀÛÀºÃ¢ÀÚ»óºÎ±îÁö X-¼± ÃÔ¿µÇϹǷνá, ±×°÷ ¼ÒÈ­°ü³»ÀÇ ÀÌ»óº´ÅÍ¿©ºÎ¸¦ °Ë»çÇϴ °Í. Á¶¿µÁ¦´Â ÁַΠ¹Ù·ýÀ» »ç¿ëÇϸ破õ ¼±¸íÇÑ ¿µ»óÀ» ¾ò±âÀ§ÇØ ¹ßÆ÷Á¦¸¦ ÇÔ²² ¼·ÃëÇÏ¿© ¹Ù·ý°ú °ø±âÀÇ ÀÌÁßÁ¶¿µÃÔ¿µÀ» Çϱ⵵ ÇÑ´Ù. ½Äµµ¾Ï, À§¾Ï ¹× ¼ÒÈ­¼º±Ë¾ç°ú ±×¹Û¿¡ ´Ù¾çÇÑ º´º¯ÀÇ Áø´Ü¿¡ È¿°úÀûÀ¸·Î »ç¿ëµÈ´Ù.
¿µ¹® small bowel series ÇÑ±Û ÀÛÀºÃ¢ÀÚ Á¶¿µ¼ú, ¼ÒÀå Á¶¿µ¼ú
¼³¸í   
  ¹æ»ç¼± Á¶¿µÁ¦(¹æ»ç¼±°Ë»ç¿¡¼­ ´Ù¸¥ ºÎÀ§¿Í ´ëÁ¶µÇ´Â ¾ÆÁÖ Èò»öÀ» ¶ì´Â ¹°Áú)ÀΠ¹Ù·ýÀ» ¼·ÃëÇÑ µÚ, ÃÔ¿µÇϴ ÀÛÀºÃ¢ÀÚÀÇ ±âº»ÀûÀΠ¹æ»ç¼± °Ë»ç·Î¼­, ¹æ¹ýÀº 200~300mLÀÇ ¹Ù·ýÀ» ¸ÔÀºµÚ ¹Ù·ýÀÌ ÀÛÀº Ã¢ÀÚ¸¦ Åë°úÇϴ µ¿¾È Á¤±ÔÀû °£°ÝÀ¸·Î ¹æ»ç¼± »çÁøÀ» ÂïÀ½. ÀϹÝÀûÀ¸·Î 2~3½Ã°£ÀÌ °É¸².
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • oxygen toxicity
    »ê¼Òµ¶¼º
  • case report
    Áõ·Êº¸°í, »ç·Êº¸°í
  • medical examination report
    ÀÇÇÐÀû°Ë»çº¸°í, °Ç°­Áø´Ü¼­
  • report
    º¸°í
  • aromatic series
    ¹æÇâÁ·°è¿­
  • aliphatic series
    Áö¹æÁ·°è¿­
  • discrete series
    ºÒ¿¬¼Ó¼ö¿­
  • exponential series
    Áö¼ö±Þ¼ö
  • granulocytic series
    °ú¸³±¸°è¿­
  • homologous series
    µ¿Á·°è¿­
  • ionization series
    ÀÌ¿ÂÈ­°è¿­
  • lymphocyte series
    ¸²ÇÁ±¸°è¿­
  • series
    1. °è¿­ 2. ±Þ¼ö 3. Á÷·Ä
  • series elastic component
    Á÷¿­Åº·Â¼ººÐ
  • series limit
    °è¿­±ØÇÑ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • series
    °è¿­, ±Þ¼ö
  • toxicity
    µ¶¼º
  • report
    º¸°í
  • case report
    Áõ·Êº¸°í
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • case report
    Áõ·Êº¸°í
  • free radical formation toxicity
    ÀÚÀ¯·¡µðÄ®Çü¼ºµ¶¼º
  • medical examination report
    ÀÇÇÐÀû°Ë»çº¸°í, °Ç°­Áø´Ü¼­
  • report
    º¸°í
  • selective toxicity
    ¼±ÅÃÀûµ¶¼º
  • toxicity
    µ¶¼º
  • aliphatic series
    Áö¹æ°è¿­
  • aromatic series
    ¹æÇâÁ·°è¿­
  • commutator series
    ±³È¯ÀÚ¿­
  • series elastic component
    Á÷¿­Åº·Â¼ººÐ
  • discrete series
    ºÒ¿¬¼Ó¼ö¿­
  • exponential series
    Áö¼ö±Þ¼ö
  • granulocytic series
    °ú¸³±¸°è¿­
  • homologous series
    µ¿Á·°è¿­
  • hypergeometric series
    ÃʱâÇϱ޼ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accident report
    »ç°Çº¸°í¼­.
  • acetaldehyder toxicity
    ¾Æ¼¼Æ®¾Ëµ¥È÷µå µ¶¼º(¡­Ô¸àõ)
  • acetaminophen toxicity
    ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ µ¶¼º(¡­Ô¸àõ)
  • acute toxicity
    ±Þ¼º Áßµ¶, ±Þ¼º µ¶¼º(¡­Ô¸àõ).
  • anesthetic toxicity
    ¸¶ÃëÁ¦µ¶¼º.
  • halothane, toxicity
    ÇÒ·Îź µ¶¼º
  • Hofmeister s series =lyotropic s.
    È£ÇÁ¸¶À̽ºÅͰ迭(¡­Í§æê).
  • aliphatic series
    Áö¹æ°è¿­.
  • arithmetic series
    µîÂ÷±Þ¼ö.
  • aromatic series
    ¹æÇâÁ·¿­(¡­ðéæê).
  • gallbladder series
    ´ã³¶Á¶¿µ°Ë»ç.
  • gallbladder series
    ´ã³²Á¶¿µ°Ë»ç
  • homologous series
    µ¿Á·°è¿­(¡­Í§æê).
  • hypergeometric series
    ÃʱâÇϱ޼ö(̧˻̰˻Ëà).
  • principal series
    ÁÖ°è¿­(̡˭Ëç).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gastrointestinal series =GI series
    ¹æ»ç À§Àå°üÁ¶¿µ¼ú.
  • accident report
    »ç°Çº¸°í¼­.
  • case report
    Áõ·Êº¸°í(Áõ¿¹º¸°í).
  • case report
    Áõ·Êº¸°í(ñøçÓÜÃͱ).
  • interim report
    Áß°£º¸°í.
  • medical examination report
    ÀÇÇÐÀû °Ë»çº¸ °í(¡­ÜÃͱ), °Ç°­Áø´Ü¼­(ËíˬòàÓ¨ßö).
  • result report
    °á°úº¸°í
  • yearly report
    ¿¬º¸(ËçËÓ).
  • acetaldehyder toxicity
    ¾Æ¼¼Æ®¾Ëµ¥È÷µå µ¶¼º(¡­Ô¸àõ)
  • acetaminophen toxicity
    ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ µ¶¼º(¡­Ô¸àõ)
  • acute toxicity
    ±Þ¼º Áßµ¶, ±Þ¼º µ¶¼º(¡­Ô¸àõ).
  • anesthetic toxicity
    ¸¶ÃëÁ¦µ¶¼º.
  • behavioral toxicity
    Çൿµ¶¼º(ú¼ÔÑÔ¸àõ)
  • carbon monoxide toxicity
    ÀÏ»êȭź¼Òµ¶¼º
  • chronic toxicity
    ¸¸¼ºµ¶¼º(Ø·àõÔ¸àõ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chronic toxicity test
    ¸¸¼º µ¶¼º½ÃÇè(Ø·àõÔ¸àõãËúÐ)
  • selective toxicity
    ¼±ÅÃÀûµ¶¼º(àÔ÷ÉîÜÔ¸àõ)
  • toxicity
    µ¶¼º(Ô¸àõ)
  • toxicity index
    µ¶¼ºÁö¼ö (Ô¸àõò¦â¦)
  • chaotropic series
    ¹«Áú¼­(Ùíòñßí) ¾¾¸®½º
  • decay series
    "ºØ±« °è¿­(ÝÚÎÕ֪ͧ), (µ¿) radioactive series"
  • eluotropic series
    ¿ë¸® ¼­¿­ (éÁ×îßíÖª)
  • globo-series glycosphingolipids
    ±Û·Îº¸°è¿­(֪ͧ) ´ç(ÓØ)½ºÇΰíÁöÁú(ò·òõ)
  • Hofmeister series
    È£ÇÁ¸¶À̽ºÅÍ °è¿­(֪ͧ)
  • homologous series
    µ¿Á· °è¿­(ÔÒðé֪ͧ)
  • lacto-series glycosphingolipid
    ¶ôÅä°è¿­(֪ͧ) ±Û¶óÀÌÄÚ½ºÇΰíÁöÁú(ò·òõ)
  • lyotropic series
    À̾װ迭(ìÆäû֪ͧ)
  • radioactive series
    ¹æ»ç¼º °è¿­(Û¯ÞÒàõ֪ͧ)
  • Trappe's eluotropic series
    Æ®¶óÆä ¿ë¸®¼­¿­(éÁ×îßíÖª)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • toxicity
    µ¶¼º, µ¶·Â
  • case report
    Áõ·Êº¸°í
  • gallbladder series
    ´ã³¶Á¶¿µ°Ë»ç
  • gastrointestinal series
    À§Àå°üÁ¶¿µ¼ú
  • preliminary report
    ¿¹º¸, Ãʱ⺸°í
  • report
    º¸°í
  • small bowel series
    ¼ÒÀåÁ¶¿µ¼ú
  • upper gastrointestinal series
    »óºÎÀ§Àå°üÁ¶¿µ¼ú
  • yearly report
    ¿¬º¸
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
EUROTOX European Committee on Chronic Toxicity Hazards
I&T intolerance and toxicity
TCLP Toxicity Characteristic Leachate Procedure [EPA battery test]
tox toxicity, toxic
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SEC Series elastic component
SAS-SR Social Adjustment Scale Self-Report
TRF Teacher Report Form
YSR Youth Self Report
CTC Common Toxicity Criteria
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 26806
    JournalTitle: Toxicity report series.
    MedAbbr: Toxic Rep Ser
    ISSN: 1521-4621
    ESSN:
    IsoAbbr:
    NlmId: 101122696
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • incident report mechanism
    »ç°Ç º¸°í ±âÀü
  • narrative report
    ÀÓ»ó º¸°í¼­
    ÁÖ¾îÁø ȯÀÚ¿¡ ´ëÇØ ÀÌ·ç¾îÁö´Â ÀÓ»óÀû ¼Ò°ß, Áø´Ü, Ä¡·á¸¦ ÀüüÀûÀ¸·Î ¹¦»çÇÑ ±â·Ï.
  • preliminary report
    ¿¹º¸, Ãʱ⠺¸°í
  • report
    º¸°í
  • acute toxicity
    ±Þ¼º Áßµ¶, ±Þ¼º µ¶¼º
  • anesthetic toxicity
    ¸¶ÃëÁ¦ µ¶¼º
  • aromatic series
    ¹æÇâÁ· ¿­
  • Balmer's series
    ¹ß¸Ó °è¿­
  • case-series evaluation
    »ç·Ê Æò°¡
  • chronic toxicity
    ¸¸¼º µ¶¼º
  • electrochemical series
    Àü±â È­ÇÐ ¼­¿­
  • homologous series
    µ¿Á· °è¿­
  • mercury toxicity
    ¼öÀº µ¶¼º
  • oxygen toxicity
    »ê¼Ò µ¶¼º
  • selective toxicity
    ¼±Åà µ¶¼º
    ¼÷ÁÖ ¼¼Æ÷¿Í ±â»ý ¼¼Æ÷¿¡ ÀÛ¿ëÇÏ´Â µ¶¼ºÀÇ »óÀÌ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
meeting report A published record of the presentations at a meeting of a society, association, or similar body or of transactions at a symposium, colloquium, seminar, workshop, round table, conference, or congress. Mere notification of the date and place of the meeting is not within the scope of this publication type. It is to be used, rather, for the proceedings or transactions of the sessions, often with presentation of papers.
(12 Dec 1998)
technical report A formal report giving details of the investigation and results of a medical or other scientific problem. When issued by a government agency or comparable official body, its contents may be classified, unclassified, or declassified with regard to security clearance. This publication type may also cover a scientific paper or article that records the current state or current position of scientific research and development. If so labelled by the editor or publisher, this publication type may be properly used for journal articles.
(12 Dec 1998)
acute toxicity <pharmacology> Illness resulting from a single dose or exposure to a toxic substance.
Compare: chronic toxicity.
(06 May 1997)
chronic toxicity <pharmacology> Illness caused by repeated or long-term exposure to low doses of a toxic substance.
Compare: acute toxicity.
(09 Oct 1997)
digitalis toxicity A result of the over-accumulation of digitalis glycosides in the body. Kidney insufficiency can be a contributing factor.
Symptoms include nausea, vomiting, visual changes, blurred vision, anorexia and palpitations. Treatment is emergent as life-threatening cardiac arrhythmias are possible with higher blood levels.
(27 Sep 1997)
digoxin toxicity A result of the over-accumulation of digitalis glycosides in the body. Kidney insufficiency can be a contributing factor.
Symptoms include nausea, vomiting, visual changes, blurred vision, anorexia and palpitations. Treatment is emergent as life-threatening cardiac arrhythmias are possible with higher blood levels.
(27 Sep 1997)
drug toxicity The systemic effects of a drug that are related to the overall level of the medication in the bloodstream. Drug toxicity may occur with overdosage of a medication, accumulation of the drug in the body over time or the inability of the patients body to eliminate the drug.
(27 Sep 1997)
oxygen toxicity A body disturbance resulting from breathing high partial pressures of oxygen; characterised by visual and hearing abnormalities, unusual fatigue while breathing, muscular twitching, anxiety, confusion, incoordination, and convulsions; although the mechanism for development of the condition is obscure, a disruption of enzymatic activity is likely, perhaps as a result of free radical formation.
Synonym: oxygen poisoning.
(05 Mar 2000)
toxicity The quality of being poisonous, especially the degree of virulence of a toxic microbe or of a poison.
(18 Nov 1997)
toxicity test <investigation> Controlled laboratory test to determine the toxicity of a chemical to an organism in terms of specific chemical concentrations.
An acute toxicity test establishes the concentration required to kill a predetermined proportion of test organisms within a relatively short period of time, typically 4 days or less. A chronic toxicity test reveals the effects of a sublethal concentration applied throughout all or part of the life cycle.
(12 Jan 1998)
toxicity tests Tests that determine the toxicity of a substance. These include tests of clinical drugs, foods, environmental pollutants, etc.
(12 Dec 1998)
ep toxicity A test defined by the federal Environmental Protection Agency to check a substance for the presence of arsenic, barium, cadmium, chromium, lead, mercury, selenium, or silver. 40 CFR 261.24 defines the concentrations constituting hazardous waste and the test procedure.
(05 Dec 1998)
aromatic series All the compounds derived from benzene, or similar cyclic compounds that obey Huckel's rule, distinguished from those compounds that are acyclic or that contain rings that lack the conjugated double bond structure characteristic of benzene.
(05 Mar 2000)
granulocytic series <haematology> The cells in the several stages of development in the bone marrow leading to the mature granulocyte of the circulation, e.g., myeloblasts, different stages of the myelocyte, granulocytes.
(05 Mar 2000)
myeloid series The granulocytic and the erythrocytic series.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • toxicity
    (À¯)µ¶¼º
  • report
    º¸µµÇÏ´Ù,ÀüÇÏ´Ù,º¸µµ,±â»ç,ÆòÆÇ
  • Economic Report
    (¹Ì±¹ ´ëÅë·ÉÀÇ)°æÁ¦ º¸°í(¿¬ÃÊ¿¡ »óÇÏ ¾ç¿ø¿¡ º¸³¿)
  • Kinsey's report
    ŲÁ¦ÀÌ º¸°í
  • damaged baggage report
    ¼öÇϹ° ÆÄ¼Õ ½Å°í¼­(½Â°´ÀÇ ÆÄ¼ÕµÈ ¼öÇϹ°¿¡ ´ëÇÑ Ç×°øÈ¸»çÀÇ Á¶»ç¼­)
  • interim report
    Áß°£º¸°í
  • reception report
    ¼ö½Å(ûÃë)º¸°í
  • report
    (Á¶»ç.¿¬±¸ÀÇ)º¸°í(¼­);¸®Æ÷Æ®;°øº¸;(Çб³ÀÇ)¼ºÀûÇ¥;(½Å¹®µîÀÇ)º¸µµ;±â»ç;ÆÇ·ÊÁý;ÀÇ»ç·Ï;(°­¿¬.Åä·ÐµîÀÇ)¼Ó±â·Ï;¼Ò¹®;¼¼Æò;ÆòÆÇ;ÆøÀ½;ÄçÇϴ¼Ҹ®;ÃѼº;Æ÷¼º;(¿¬±¸.Á¶»ç µîÀ»)º¸°íÇÏ´Ù;(µéÀº °ÍÀ»)ÀüÇÏ´Ù;¸»ÇÏ´Ù;°øÇ¥ÇÏ´Ù;(...°¡)...¶ó°í ¸»ÇÏ´Ù;(ÀÇ»ç.°­¿¬µîÀ»)±â·ÏÇÏ´Ù;(±â
  • report card
    (Çб³ÀÇ)¼ºÀûÇ¥;ÅëÁöÇ¥
  • report stage
    (Á¦ 3µ¶È¸ Àü¿¡ ÇÏ´Â)À§¿øÈ¸ º¸°íÀÇ ½ÉÀÇ
  • weather report
    Àϱ⠿¹º¸
  • a series fo
    ÀÏ·ÃÀÇ
  • series
    ¿¬¼ÓµÈ °Í
  • actinide series
    ¾ÇƼ´Ïµå °è¿­;¹æ»ç¼±¿ø¼Ò
  • arithmetic series
    µîÂ÷±Þ¼ö
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á